Trending Stock News

Mutual Of Omaha Bank Wealth Management Decreased Its Intel (INTC) Position; Acceleron Pharma Inc. (XLRN) Covered By 11 Bullish Analysts Last Week

Mutual Of Omaha Bank Wealth Management decreased Intel Corp (INTC) stake by 76.57% reported in 2017Q3 SEC filing. Mutual Of Omaha Bank Wealth Management sold 53,000 shares as Intel Corp (INTC)’s stock declined 2.96%. The Mutual Of Omaha Bank Wealth Management holds 16,220 shares with $617,000 value, down from 69,220 last quarter. Intel Corp now has $216.78B valuation. The stock increased 1.67% or $0.76 during the last trading session, reaching $46.32. About 25.51M shares traded. Intel Corporation (NASDAQ:INTC) has risen 19.47% since February 21, 2017 and is uptrending. It has outperformed by 2.77% the S&P500.

Among 16 analysts covering Acceleron Pharma (NASDAQ:XLRN), 11 have Buy rating, 1 Sell and 4 Hold. Therefore 69% are positive. Acceleron Pharma had 35 analyst reports since August 13, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Janney Capital on Thursday, December 17. Credit Suisse downgraded Acceleron Pharma Inc. (NASDAQ:XLRN) rating on Thursday, September 21. Credit Suisse has “Hold” rating and $35.0 target. The firm has “Outperform” rating by Oppenheimer given on Tuesday, December 13. H.C. Wainwright initiated it with “Buy” rating and $62.0 target in Monday, January 8 report. Barclays Capital initiated the stock with “Overweight” rating in Wednesday, April 27 report. The firm has “Outperform” rating given on Monday, February 1 by Oppenheimer. UBS maintained Acceleron Pharma Inc. (NASDAQ:XLRN) on Tuesday, September 12 with “Buy” rating. The company was maintained on Thursday, June 1 by Oppenheimer. Citigroup initiated Acceleron Pharma Inc. (NASDAQ:XLRN) rating on Thursday, September 29. Citigroup has “Neutral” rating and $40 target. As per Friday, October 6, the company rating was maintained by Piper Jaffray. See Acceleron Pharma Inc. (NASDAQ:XLRN) latest ratings:

08/01/2018 Broker: H.C. Wainwright Rating: Buy New Target: $62.0 Initiate
14/11/2017 Broker: Credit Suisse Rating: Outperform Old Target: $35 New Target: $51 Maintain
02/11/2017 Broker: RBC Capital Markets Rating: Hold New Target: $44.0 Maintain
12/10/2017 Broker: H.C. Wainwright Rating: Buy New Target: $57 Initiates Coverage On
06/10/2017 Broker: Piper Jaffray Rating: Buy New Target: $40.0 Maintain
21/09/2017 Broker: Credit Suisse Rating: Hold New Target: $35.0 Downgrade
20/09/2017 Broker: Barclays Capital Rating: Overweight Old Target: $42 New Target: $50 Maintain
15/09/2017 Broker: RBC Capital Markets Rating: Sector Perform New Target: $44 Initiates Coverage On
12/09/2017 Broker: UBS Rating: Buy New Target: $50.0 Maintain

Since September 12, 2017, it had 1 insider purchase, and 12 selling transactions for $19.61 million activity. Shares for $196,423 were sold by Quisel John D. Another trade for 105,122 shares valued at $3.76 million was sold by George Jean. CELGENE CORP /DE/ bought $27.59 million worth of stock or 745,592 shares. 4,300 shares were sold by Kumar Ravindra, worth $182,363. $614,546 worth of Acceleron Pharma Inc. (NASDAQ:XLRN) was sold by MCLAUGHLIN KEVIN F. On Friday, January 12 the insider Rovaldi Christopher sold $495,000. On Tuesday, September 12 Sherman Matthew L sold $706,799 worth of Acceleron Pharma Inc. (NASDAQ:XLRN) or 18,400 shares.

Investors sentiment increased to 1.81 in 2017 Q3. Its up 0.37, from 1.44 in 2017Q2. It increased, as 12 investors sold Acceleron Pharma Inc. shares while 30 reduced holdings. 30 funds opened positions while 46 raised stakes. 37.73 million shares or 12.48% more from 33.54 million shares in 2017Q2 were reported. Bank Of America Corp De has 97,468 shares for 0% of their portfolio. 1.07M are owned by Polar Cap Limited Liability Partnership. Vanguard Group owns 2.33 million shares. 43,150 were accumulated by Alliancebernstein Ltd Partnership. Northern Corp holds 0% or 380,917 shares in its portfolio. Iguana Health Limited Liability Corp holds 70,000 shares or 1.46% of its portfolio. Century Cos Incorporated owns 31,964 shares. Gsa Cap Ptnrs Ltd Liability Partnership invested in 40,099 shares. Ameriprise Fin Incorporated accumulated 33,430 shares. National Bank Of Mellon reported 165,645 shares. Blackrock holds 0.01% or 4.30 million shares. California Employees Retirement System has invested 0% in Acceleron Pharma Inc. (NASDAQ:XLRN). Oppenheimer & Com holds 6,031 shares or 0.01% of its portfolio. Nationwide Fund Advsrs has invested 0.01% in Acceleron Pharma Inc. (NASDAQ:XLRN). Tiaa Cref Mngmt Ltd Llc invested in 0% or 83,849 shares.

The stock increased 1.38% or $0.58 during the last trading session, reaching $42.55. About 359,372 shares traded or 15.98% up from the average. Acceleron Pharma Inc. (NASDAQ:XLRN) has declined 22.43% since February 21, 2017 and is downtrending. It has underperformed by 39.13% the S&P500.

Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for serious and rare diseases. The company has market cap of $1.93 billion. The Company’s therapeutic candidates include luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassemia; and sotatercept for chronic kidney diseases. It currently has negative earnings. The companyÂ’s therapeutic candidates also include dalantercept, a tyrosine kinase inhibitor, which is in phase II clinical trials for renal cell carcinoma; and ACE-083 that is in phase II clinical trials for facioscapulohumeral dystrophy.

Since October 2, 2017, it had 0 insider purchases, and 16 selling transactions for $30.87 million activity. Smith Stacy J had sold 472,337 shares worth $20.89 million. On Monday, October 30 the insider YOFFIE DAVID B sold $1.35 million. On Monday, October 23 Bryant Diane M sold $67,048 worth of Intel Corporation (NASDAQ:INTC) or 1,639 shares. Another trade for 8,659 shares valued at $427,757 was sold by Krzanich Brian M. BRYANT ANDY D also sold $3.99M worth of Intel Corporation (NASDAQ:INTC) on Monday, October 30. 1,502 Intel Corporation (NASDAQ:INTC) shares with value of $66,959 were sold by RENDUCHINTALA VENKATA S M. Another trade for 2,155 shares valued at $98,336 was sold by Shenoy Navin.

Analysts await Intel Corporation (NASDAQ:INTC) to report earnings on April, 26. They expect $0.71 EPS, up 7.58% or $0.05 from last year’s $0.66 per share. INTC’s profit will be $3.32 billion for 16.31 P/E if the $0.71 EPS becomes a reality. After $1.08 actual EPS reported by Intel Corporation for the previous quarter, Wall Street now forecasts -34.26% negative EPS growth.

Among 54 analysts covering Intel Corporation (NASDAQ:INTC), 36 have Buy rating, 5 Sell and 13 Hold. Therefore 67% are positive. Intel Corporation had 222 analyst reports since August 7, 2015 according to SRatingsIntel. Needham maintained the stock with “Buy” rating in Monday, September 19 report. The stock of Intel Corporation (NASDAQ:INTC) has “Outperform” rating given on Thursday, October 8 by Northland Capital. Deutsche Bank maintained Intel Corporation (NASDAQ:INTC) rating on Monday, January 4. Deutsche Bank has “Buy” rating and $38 target. The firm has “Buy” rating given on Friday, October 27 by Bank of America. The firm has “Sector Perform” rating by RBC Capital Markets given on Friday, April 1. The firm has “Buy” rating by Summit Research given on Wednesday, October 14. The stock of Intel Corporation (NASDAQ:INTC) has “Buy” rating given on Monday, September 19 by Jefferies. As per Thursday, July 21, the company rating was maintained by Oppenheimer. Drexel Hamilton downgraded the stock to “Hold” rating in Friday, August 7 report. Roth Capital maintained Intel Corporation (NASDAQ:INTC) rating on Friday, October 20. Roth Capital has “Buy” rating and $43.0 target.

Investors sentiment is 1.03 in Q3 2017. Its the same as in 2017Q2. It is without change, as 52 investors sold INTC shares while 663 reduced holdings. only 127 funds opened positions while 608 raised stakes. 3.05 billion shares or 0.19% more from 3.05 billion shares in 2017Q2 were reported. The Virginia-based Investment Mngmt Of Virginia Ltd Liability has invested 1.3% in Intel Corporation (NASDAQ:INTC). Commonwealth Equity Services Incorporated reported 1.67M shares. Moreover, Mark Sheptoff Financial Planning Limited Liability Corp has 0.22% invested in Intel Corporation (NASDAQ:INTC) for 8,800 shares. Cibc Markets has 0.48% invested in Intel Corporation (NASDAQ:INTC). 319,970 are held by Twin Management. Inverness Counsel Lc Ny invested in 0.02% or 7,500 shares. Monroe Bancorporation And Trust Mi reported 27,961 shares. Iowa Natl Bank invested in 1.64% or 91,141 shares. Voya Ltd Liability invested in 0.2% or 2.49 million shares. 133,952 were accumulated by Stellar Capital Mngmt Ltd Llc. Wall Street Access Asset Mngmt Ltd Liability has 0.92% invested in Intel Corporation (NASDAQ:INTC). Central National Bank And Tru Company, a Kentucky-based fund reported 18,402 shares. Botty Investors Limited Liability Corporation has 1.43% invested in Intel Corporation (NASDAQ:INTC) for 117,968 shares. Moreover, First Citizens Natl Bank Trust has 1.05% invested in Intel Corporation (NASDAQ:INTC). Aviance Capital Ptnrs Limited Liability holds 1.57% or 122,146 shares.

Leave a Reply

Your email address will not be published. Required fields are marked *